Report Detail
Global Dexlansoprazole Sustained Release Capsule Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM4533433 |
- 08 June, 2023 |
- Global |
- 71 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Dexlansoprazole Sustained Release Capsule market size was valued at USD 306.6 million in 2022 and is forecast to a readjusted size of USD 433.5 million by 2029 with a CAGR of 5.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Dexlansoprazole sustained-release capsules were approved by the U.S. FDA in January 2009, under the trade name DEXILANT. For the treatment of heartburn caused by non-erosive gastroesophageal reflux disease (GERD), erosive esophagitis (EE) and maintenance treatment after healing of erosive esophagitis, all of which are administered once a day.
This report is a detailed and comprehensive analysis for global Dexlansoprazole Sustained Release Capsule market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Dexlansoprazole Sustained Release Capsule market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Dexlansoprazole Sustained Release Capsule market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Dexlansoprazole Sustained Release Capsule market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Dexlansoprazole Sustained Release Capsule market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Dexlansoprazole Sustained Release Capsule
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Dexlansoprazole Sustained Release Capsule market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include TAKEDA PHARM, PAR PHARM and TWI PHARM. etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Dexlansoprazole Sustained Release Capsule market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
30MG
60MG
Market segment by Application
Hospital
Clinic
Major players covered
TAKEDA PHARM
PAR PHARM
TWI PHARM
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dexlansoprazole Sustained Release Capsule product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Dexlansoprazole Sustained Release Capsule, with price, sales, revenue and global market share of Dexlansoprazole Sustained Release Capsule from 2018 to 2023.
Chapter 3, the Dexlansoprazole Sustained Release Capsule competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dexlansoprazole Sustained Release Capsule breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Dexlansoprazole Sustained Release Capsule market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Dexlansoprazole Sustained Release Capsule.
Chapter 14 and 15, to describe Dexlansoprazole Sustained Release Capsule sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Dexlansoprazole Sustained Release Capsule
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Dexlansoprazole Sustained Release Capsule Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 30MG
- 1.3.3 60MG
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Dexlansoprazole Sustained Release Capsule Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.5 Global Dexlansoprazole Sustained Release Capsule Market Size & Forecast
- 1.5.1 Global Dexlansoprazole Sustained Release Capsule Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Dexlansoprazole Sustained Release Capsule Sales Quantity (2018-2029)
- 1.5.3 Global Dexlansoprazole Sustained Release Capsule Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 TAKEDA PHARM
- 2.1.1 TAKEDA PHARM Details
- 2.1.2 TAKEDA PHARM Major Business
- 2.1.3 TAKEDA PHARM Dexlansoprazole Sustained Release Capsule Product and Services
- 2.1.4 TAKEDA PHARM Dexlansoprazole Sustained Release Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 TAKEDA PHARM Recent Developments/Updates
- 2.2 PAR PHARM
- 2.2.1 PAR PHARM Details
- 2.2.2 PAR PHARM Major Business
- 2.2.3 PAR PHARM Dexlansoprazole Sustained Release Capsule Product and Services
- 2.2.4 PAR PHARM Dexlansoprazole Sustained Release Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 PAR PHARM Recent Developments/Updates
- 2.3 TWI PHARM
- 2.3.1 TWI PHARM Details
- 2.3.2 TWI PHARM Major Business
- 2.3.3 TWI PHARM Dexlansoprazole Sustained Release Capsule Product and Services
- 2.3.4 TWI PHARM Dexlansoprazole Sustained Release Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 TWI PHARM Recent Developments/Updates
3 Competitive Environment: Dexlansoprazole Sustained Release Capsule by Manufacturer
- 3.1 Global Dexlansoprazole Sustained Release Capsule Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Dexlansoprazole Sustained Release Capsule Revenue by Manufacturer (2018-2023)
- 3.3 Global Dexlansoprazole Sustained Release Capsule Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Dexlansoprazole Sustained Release Capsule by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Dexlansoprazole Sustained Release Capsule Manufacturer Market Share in 2022
- 3.4.2 Top 6 Dexlansoprazole Sustained Release Capsule Manufacturer Market Share in 2022
- 3.5 Dexlansoprazole Sustained Release Capsule Market: Overall Company Footprint Analysis
- 3.5.1 Dexlansoprazole Sustained Release Capsule Market: Region Footprint
- 3.5.2 Dexlansoprazole Sustained Release Capsule Market: Company Product Type Footprint
- 3.5.3 Dexlansoprazole Sustained Release Capsule Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Dexlansoprazole Sustained Release Capsule Market Size by Region
- 4.1.1 Global Dexlansoprazole Sustained Release Capsule Sales Quantity by Region (2018-2029)
- 4.1.2 Global Dexlansoprazole Sustained Release Capsule Consumption Value by Region (2018-2029)
- 4.1.3 Global Dexlansoprazole Sustained Release Capsule Average Price by Region (2018-2029)
- 4.2 North America Dexlansoprazole Sustained Release Capsule Consumption Value (2018-2029)
- 4.3 Europe Dexlansoprazole Sustained Release Capsule Consumption Value (2018-2029)
- 4.4 Asia-Pacific Dexlansoprazole Sustained Release Capsule Consumption Value (2018-2029)
- 4.5 South America Dexlansoprazole Sustained Release Capsule Consumption Value (2018-2029)
- 4.6 Middle East and Africa Dexlansoprazole Sustained Release Capsule Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Dexlansoprazole Sustained Release Capsule Sales Quantity by Type (2018-2029)
- 5.2 Global Dexlansoprazole Sustained Release Capsule Consumption Value by Type (2018-2029)
- 5.3 Global Dexlansoprazole Sustained Release Capsule Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Dexlansoprazole Sustained Release Capsule Sales Quantity by Application (2018-2029)
- 6.2 Global Dexlansoprazole Sustained Release Capsule Consumption Value by Application (2018-2029)
- 6.3 Global Dexlansoprazole Sustained Release Capsule Average Price by Application (2018-2029)
7 North America
- 7.1 North America Dexlansoprazole Sustained Release Capsule Sales Quantity by Type (2018-2029)
- 7.2 North America Dexlansoprazole Sustained Release Capsule Sales Quantity by Application (2018-2029)
- 7.3 North America Dexlansoprazole Sustained Release Capsule Market Size by Country
- 7.3.1 North America Dexlansoprazole Sustained Release Capsule Sales Quantity by Country (2018-2029)
- 7.3.2 North America Dexlansoprazole Sustained Release Capsule Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Dexlansoprazole Sustained Release Capsule Sales Quantity by Type (2018-2029)
- 8.2 Europe Dexlansoprazole Sustained Release Capsule Sales Quantity by Application (2018-2029)
- 8.3 Europe Dexlansoprazole Sustained Release Capsule Market Size by Country
- 8.3.1 Europe Dexlansoprazole Sustained Release Capsule Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Dexlansoprazole Sustained Release Capsule Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Dexlansoprazole Sustained Release Capsule Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Dexlansoprazole Sustained Release Capsule Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Dexlansoprazole Sustained Release Capsule Market Size by Region
- 9.3.1 Asia-Pacific Dexlansoprazole Sustained Release Capsule Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Dexlansoprazole Sustained Release Capsule Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Dexlansoprazole Sustained Release Capsule Sales Quantity by Type (2018-2029)
- 10.2 South America Dexlansoprazole Sustained Release Capsule Sales Quantity by Application (2018-2029)
- 10.3 South America Dexlansoprazole Sustained Release Capsule Market Size by Country
- 10.3.1 South America Dexlansoprazole Sustained Release Capsule Sales Quantity by Country (2018-2029)
- 10.3.2 South America Dexlansoprazole Sustained Release Capsule Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Dexlansoprazole Sustained Release Capsule Market Size by Country
- 11.3.1 Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Dexlansoprazole Sustained Release Capsule Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Dexlansoprazole Sustained Release Capsule Market Drivers
- 12.2 Dexlansoprazole Sustained Release Capsule Market Restraints
- 12.3 Dexlansoprazole Sustained Release Capsule Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 12.5 Influence of COVID-19 and Russia-Ukraine War
- 12.5.1 Influence of COVID-19
- 12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
- 13.1 Raw Material of Dexlansoprazole Sustained Release Capsule and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Dexlansoprazole Sustained Release Capsule
- 13.3 Dexlansoprazole Sustained Release Capsule Production Process
- 13.4 Dexlansoprazole Sustained Release Capsule Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Dexlansoprazole Sustained Release Capsule Typical Distributors
- 14.3 Dexlansoprazole Sustained Release Capsule Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Dexlansoprazole Sustained Release Capsule. Industry analysis & Market Report on Dexlansoprazole Sustained Release Capsule is a syndicated market report, published as Global Dexlansoprazole Sustained Release Capsule Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Dexlansoprazole Sustained Release Capsule market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
